Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01840826 · ClinicalTrials.gov registry record · NA
Reducing Hospital Readmissions in Patients With Depressive Symptoms
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 709
- Enrollment target
NCT01840826 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 709 participants.
The verdict
NCT01840826, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 709 participants
- Enrollment target
Study Summary
Project Re-Engineered Discharge (Project RED) has previously demonstrated that patients who received the RED were 30% less likely than patients receiving usual care to access inpatient or emergency services within 30 days of discharge. In this project, the investigators add a new dimension to RED by integrating screening, referral and treatment for depression into the original RED intervention and determining if this enhanced intervention increases the effectiveness of RED in preventing readmissions and controlling costs in the 180 days after discharge for patients with signs of depression.
Interventions
- OTHER RED-D Care Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 709 participants |
| Start Date | 2013-02 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01840826
The ClinicalTrials.gov registry entry for NCT01840826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 709 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RED-D Care Management is the first listed.
NCT01840826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01840826 about?
NCT01840826 is a clinical study titled "Reducing Hospital Readmissions in Patients With Depressive Symptoms". Project Re-Engineered Discharge (Project RED) has previously demonstrated that patients who received the RED were 30% less likely than patients receiving usual care to access inpatient or emergency services within 30 days of discharge. In this project, the investigators add a new dimension to RED by...
What is the current status of trial NCT01840826?
This trial is currently completed. It is a NA study. The enrollment target is 709 participants. The study started on 2013-02. Estimated completion is 2018-02.
What interventions are being tested in trial NCT01840826?
The interventions under investigation include: RED-D Care Management (OTHER).
Who is sponsoring clinical trial NCT01840826?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.